Harvard Case Study Kramer Pharmaceuticals‚ Inc. By: Derek A. Newton Management “Honors” 3300 Section EMWA Professor Walsh Kris Bonilla Daniella DiBenedetto Fact Sheet: * Company name: Kramer Pharmaceuticals‚ Inc. * Major manufacturer of prescription drugs. * Sales force of over 500 detailers * Detailers responsible for about 200 accounts * 35 District managers * Detailer: Bob Marsh * Worked for Kramer Pharmaceuticals for 12 years * Territory
Premium Management Sales Leadership
Case 34 Lorex Pharmaceuticals Elaina Wesel MANA 6302 N1 Abstract This report will seek to outline and discuss the challenges faced by Lorex Pharmaceuticals. This report will detail the circumstances that dictated the challenge faced Lorex Pharmaceuticals‚ as well as the key areas they must consider when attempting to resolve this challenge. The report will examine the possible outcomes‚ and make a final recommendation based on the information provided. When developing a brand new product
Premium Marketing Pharmacology Management
candidates that can be further developed. Pharmaceutical companies often have relevant compounds that have not been assessed for their potential to treat colorectal cancer. The overall objective for this company‚ Arias Pharmaceuticals‚ is to help and support the discovery of new drug leads for colorectal cancer through networks and partnerships between pharmaceutical companies as well as academia. Specifically‚ the
Premium Colorectal cancer Cancer Drug discovery
profitability in the pharmaceutical industry has been declining over time (In 2002‚ the average ROIC in the industry was 21.6%; by 2006‚ it had fallen to 14.5%)‚ historically‚ the pharmaceutical industry has been a profitable one. Because- Name of industry | Average ROIC(Between 2002 and 2006) | Pharmaceuticals | 16.45%(large) | computer hardware | 12.76% | Electronics | 3.88% | 2. The prospect for the industry for going forward is very positive. Because the demand for pharmaceuticals has been strong
Premium Pharmaceutical industry Pharmacology Generic drug
productivity = 2‚117 / 2 =1‚058.5 • Lowest productivity = 1‚965 / 4 = 491.25 • Explanation: • There are many possible reasons why the productivity differs when the number of crewmembers increases or decreases. One of it is that as stated on the case the company hires new employees every year. It means that maybe the combination of workers is not effective. For example the best employees were stationed to work together and the average rated employees and their novices were grouped. This is the
Premium Output Laborer Affect
Exhibits 1‚ 2‚ and 3 suggest any problems that might explain or be related to the profit declines? It is clear that productivity gains have the potential to contribute to an increase in business profit (Lovell and Grifell-Tatjé‚ 1996). Similarly‚ the case study highlighted that‚ Clinton Pharmaceutical’s key success has always been its high productivity which resulting low unit production costs. However‚ Exhibit 1 shows that from 1999 to 2003 their productivity has been decreased by 21%. Likewise‚ their
Premium Maslow's hierarchy of needs
1. Drawing on the five forces model‚ explain why the pharmaceutical industry has historically been a very profitable? a. Rivalry among competing firms i. Patent protected medicine allows prating monopoly ii. In pharmaceutical industry they have several strong competition compete again few rather than more companies b. Threat of substitute product i. Very costly to introduce a new drugs ii. So many medicines protect by patent law‚ all competitors can make countertrend drugs who have almost
Premium Pharmacology Pharmaceutical industry Generic drug
As mentioned from the previous part there is a problem in sales‚ the purpose of the research is to figure out what causes this problem as the manager decision of the problem is to find out should the organization set new prices or not‚ furthermore what is required is to control the price elasticity of demand and the influence on sales taking into consideration the price modifications and the several levels of price changes‚ moreover the problem is considered a broad one and needs an appropriate specification
Premium Generally Accepted Accounting Principles Economics Management
Case study: Ovelle pharmaceuticals Question 1: The company ovelle was founded in 1934 in Dundalk. This Irish family business is specialized in the production of dermatological‚ pharmaceutical and beauty products. The granddaughter of the founder‚ "Joanna Gardiner" took over the company in 2000. At that time the company had few Difficulties. She had financial difficulties and was sterile in terms of innovation. Now after Joanna’s work we will diagnostic the situation of the company. For this we
Premium Entrepreneurship Market penetration Marketing
Case # 9: 7.1 Ligard Pharmaceuticals Certainly‚ an auditor would be guided by the following auditing standards: 1. AS 8.03 Audit Risk In order to express an appropriate opinion for the financial statements‚ the auditor must plan and perform the audit free of material misstatement. In this case‚ Fazio and his subordinates evaluate the risk of Ligand and posed it as a “greater than normal” degree of engagement risk‚ because Ligand had problem on its sales returns. 2. AU 210.01-03 Training and Proficiency
Premium Audit Financial audit Auditing